#commercialization

Collection of commercialization news, found 248 news.

Elevance Renewable Sciences Named Recipient of EPA Presidential Green Chemistry Award

-     Elevance Renewable Sciences, Inc., a producer of high-performance renewable specialty ...

Stiefel, a GSK Company, Enters Agreement With Welichem Biotech, Inc.

-     Stiefel, a GSK (NYSE:GSK) company, and Welichem Biotech, Inc. (WBI:CN), have entered into an ...

PneumRx, Inc. Acquires Key Assets From Broncus

-           - Acquisition bolsters PneumRx's position as a leader in ...

PneumRx, Inc. Receives FDA Approval to Commence Pivotal Clinical Trial

-Study Results Will be Used to Support PMA Application for the RePneu LVRC System     PneumRx, Inc. ...

Silverbrook Research Reaches Agreement With Memjet

-     Silverbrook Research today announced it has reached an agreement with Memjet which will ...

Memjet Reaches Key Agreement

-     Memjet today announced a key agreement that clears the way for the continued ...

Pew Report: Record $263 Billion in Global Clean Energy Investment

-                -- Asia, Oceania region ...

Jubilant and Endo Pharmaceuticals Announce Successful Delivery of Early Milestones in Collaborative

-         Jubilant Biosys Ltd., a Bengaluru-based subsidiary of Jubilant Life ...

Pope condemns commercialization of Christmas

Pope Benedict XVI has condemned the commercialization of Christmas as he held Mass at St. Peter's Basilica in the ...

Fidia Farmaceutici S.p.A. to Distribute and Promote HYALGAN® (sodium hyaluronate)

-Commercial rights to HYALGAN transitioned from Sanofi back to Fidia, the brand's owner and manufacturerWholly-owned ...

RS Components Wins 2011 EE Times ACE Award with DesignSpark PCB

-Free DesignSpark PCB professional design tool selected as Most Popular Product of the Year in IP/EDA ...

Air China Announced to Join SAFUG

-     Recently, Air China officially announced to become a member of Sustainable Aviation Fuel ...

Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metast

-      March 2011 Data Confirm Strong Treatment Effect of ...

New ESC Guidelines Recommend Efient(R) (Prasugrel) as First-line Antiplatelet Therapy for Patients w

-    In new guidelines from the European Society of Cardiology (ESC), prasugrel - a once daily oral ...

Effient(R) (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopido

-Analysis evaluated efficacy and safety among three patient sub-groups        A new ...